WO2016015055A8 - Colon cleansing compositions - Google Patents

Colon cleansing compositions Download PDF

Info

Publication number
WO2016015055A8
WO2016015055A8 PCT/US2015/042298 US2015042298W WO2016015055A8 WO 2016015055 A8 WO2016015055 A8 WO 2016015055A8 US 2015042298 W US2015042298 W US 2015042298W WO 2016015055 A8 WO2016015055 A8 WO 2016015055A8
Authority
WO
WIPO (PCT)
Prior art keywords
colon cleansing
cleansing compositions
compositions
kits
methods
Prior art date
Application number
PCT/US2015/042298
Other languages
French (fr)
Other versions
WO2016015055A1 (en
Inventor
Mark G. Currie
Caroline Kurtz
Jeffrey Johnston
Xiaobing Li
Original Assignee
Ironwood Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals, Inc. filed Critical Ironwood Pharmaceuticals, Inc.
Publication of WO2016015055A1 publication Critical patent/WO2016015055A1/en
Publication of WO2016015055A8 publication Critical patent/WO2016015055A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to compositions comprising guanylate cyclase C agonist peptides, and dosage forms, methods, and kits thereof. The compositions, dosage forms, methods and kits may be used for colon cleansing prior to colonoscopy, or in preparation for other medical, radiologic and/or surgical procedures.
PCT/US2015/042298 2014-07-25 2015-07-27 Colon cleansing compositions WO2016015055A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462028963P 2014-07-25 2014-07-25
US62/028,963 2014-07-25

Publications (2)

Publication Number Publication Date
WO2016015055A1 WO2016015055A1 (en) 2016-01-28
WO2016015055A8 true WO2016015055A8 (en) 2016-09-09

Family

ID=53777040

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2015/042298 WO2016015055A1 (en) 2014-07-25 2015-07-27 Colon cleansing compositions

Country Status (1)

Country Link
WO (1) WO2016015055A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017013928A (en) 2015-05-01 2018-01-15 Ironwood Pharmaceuticals Inc Compositions for colon cleansing and the treatment of gastrointestinal disorders.
RU2713175C1 (en) * 2019-02-04 2020-02-04 Виктор Анатольевич Маткевич Acid-mineral composition and enteral solution by matkevich for lavage of gastrointestinal tract and/or correction of homeostasis disorders
KR20220122613A (en) * 2019-12-23 2022-09-02 주식회사 비보존 colon laxative composition
CN115040512B (en) * 2022-07-28 2023-06-20 苏州中化药品工业有限公司 Pharmaceutical composition and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140179607A9 (en) * 2009-11-09 2014-06-26 Ironwood Pharmaceuticals, Inc Treatments for Gastrointestinal Disorders
US20160213739A1 (en) * 2011-05-11 2016-07-28 Ironwood Pharmaceuticals, Inc Treatments for disorders using guanylate cyclase c agonists
US9303066B2 (en) * 2011-05-11 2016-04-05 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
EP2958577A2 (en) * 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing

Also Published As

Publication number Publication date
WO2016015055A1 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
IL247659A0 (en) Antibodies against immunogenic glycopeptides, composition comprising the same and use thereof
WO2016100985A3 (en) Chimeric antigen receptors and methods of use thereof
EP3164702A4 (en) Use of fluorescent polymers in marking compositions for the diagnostic determination of cleaning performance
IL273300A (en) High dosage valbenazine formulation and compositions, methods, and kits related thereto
EP3411504A4 (en) Anti-tnf antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
WO2016060996A3 (en) Interleukin-15 compositions and uses thereof
WO2016044463A3 (en) Mk2 inhibitors and uses thereof
WO2014152157A8 (en) Methods and compositions for the generation and use of conformation-specific antibodies
WO2014180889A8 (en) Methods and compositions for the treatment of cancer
WO2015171558A3 (en) BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
EP4289820A3 (en) Compounds for use in treating alzheimer's disease in apoe4+/+ patients
SG11201705450SA (en) Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases
EP2978423A4 (en) Stable nanocomposition comprising doxorubicin, process for the preparation thereof, its use and pharmaceutical compositions containing it
EP3305802A4 (en) Novel peptide and composition containing the same
WO2016079110A3 (en) Use of enzyme for cleaning
WO2016167944A3 (en) Compositions and methods for treating autism
WO2016020210A8 (en) Factor viii formulation
WO2016140933A3 (en) Immediate release soluble ibuprofen compositions
WO2017011769A3 (en) Il-17f-specific capture agents, compositions, and methods of using and making
EP3497077A4 (en) Amide compounds, pharmaceutical compositions thereof, and methods of using the same
WO2016015055A8 (en) Colon cleansing compositions
WO2015200534A3 (en) Small molecule agonists of neurotensin receptor 1
EP4342531A3 (en) Methods of improving myocardial performance in fontan patients using udenafil compositions
WO2016094374A8 (en) Compositions and methods for treatment of friedreich's ataxia
EA201691792A1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON VILDAGLIPTINA

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15745741

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15745741

Country of ref document: EP

Kind code of ref document: A1